Medrx Co (TSE:4586) Days Payable : 0.00 (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Medrx Co Days Payable?

Medrx Co's average Accounts Payable for the three months ended in Mar. 2024 was 円0.00 Mil. Medrx Co's Cost of Goods Sold for the three months ended in Mar. 2024 was 円0.00 Mil.

The historical rank and industry rank for Medrx Co's Days Payable or its related term are showing as below:

During the past 13 years, Medrx Co's highest Days Payable was 2226.52. The lowest was 4.03. And the median was 892.88.

TSE:4586's Days Payable is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 88.69
* Ranked among companies with meaningful Days Payable only.

Medrx Co's Days Payable stayed the same from Mar. 2023 (0.00) to Mar. 2024 (0.00). stayed the same

Medrx Co Days Payable Historical Data

The historical data trend for Medrx Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medrx Co Days Payable Chart

Medrx Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

4.03

Medrx Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Medrx Co's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Medrx Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medrx Co's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medrx Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Medrx Co's Days Payable falls into.

Medrx Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Medrx Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	2.4	*	365
=	0					/	2.4	*	365
=	0.00

Medrx Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Medrx Co Days Payable Related Terms

Thank you for viewing the detailed overview of Medrx Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Medrx Co (TSE:4586) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medrx Co Ltd (TSE:4586) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712

Website

http://www.medrx.co.jp

Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.

Medrx Co (TSE:4586) Headlines

No Headlines